Amgen (AMGN) Other Operating Expenses (2009 - 2026)

Amgen's Other Operating Expenses history runs 18 years deep, the most recent figure standing at $2.6 billion for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 30.73% year-over-year to $2.6 billion; the TTM figure through Mar 2026 stood at $12.2 billion (down 10.42% YoY), while the FY2025 annual figure was $13.3 billion, up 1.85% from the prior year.
• Other Operating Expenses was $2.6 billion for Q1 2026 at Amgen, down from $3.1 billion in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $3.8 billion in Q1 2025 to a low of $1.6 billion in Q1 2022.
• Historically, Other Operating Expenses has averaged $2.7 billion across 5 years, with a median of $3.1 billion in 2025.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 36.51% in 2022, then surged 81.96% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at $1.7 billion in 2022, then soared by 81.96% to $3.1 billion in 2023, then climbed by 1.8% to $3.2 billion in 2024, then dropped by 3.81% to $3.1 billion in 2025, then fell by 13.79% to $2.6 billion in 2026.
• The last three Other Operating Expenses figures came in at $2.6 billion (Q1 2026), $3.1 billion (Q4 2025), and $3.4 billion (Q3 2025), per Business Quant data.